IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Cancer
Trial Locations (2)

19107

RECRUITING

Thomas Jefferson University, Philadelphia

97239

NOT_YET_RECRUITING

Oregon Health and Science University, Portland

All Listed Sponsors
collaborator

Thomas Jefferson University

OTHER

collaborator

Oregon Health and Science University

OTHER

lead

State University of New York at Buffalo

OTHER